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Objective: In a previous study we showed that recellularization of a stentless biopros-
thetic valve is stimulated 1 month after implantation in the pulmonary position, when
its matrix (acellular photo-oxidized bovine pericardium) was preseeded by intraperi-
toneal implantation during a 3-day period.
Methods: The present study reports on the functional and biomechanical properties
of such valves (n 5 19) in sheep up to 5 months after implantation. Similar valves
(n 5 20) that were not intraperitoneally preseeded served as controls.
Results: Recellularization was partial in control valves and excessive in preseeded
valves: 66% versus 223% of cellularity of native valves, respectively (P , .05).
The valves were endothelialized and contained interstitial cells depositing new matrix
(collagens and elastin). However, phenotyping revealed an increased proportion of
cells with contractile properties (30%–40% alpha smooth muscle actin1) in both
groups. Intraperitoneally seeded valves had thicker and shorter leaflets that were
associated with mildly increased peak gradients and regurgitation. Characterization of
the matrix properties revealed a gradually degrading matrix (625% loss of collagen
organization at 5 months) and a concomitant alteration of its biomechanical proper-
ties, that is, decreased strength, stiffness, and maximum force. However, overall valve
function remained intact, and the biomechanical properties of the whole valves were
superior to that of the native valves.
Conclusion: The ectopic in vivo seeding paradigm provides full recellularization.
However, the volume fraction of the cellular phenotypes is not optimal, resulting in
inadequate remodeling of the valves.
I
n a recent overview, Rabkin and Schoen1 classified the paradigms used in cardio-
vascular tissue engineering. The classic in vitro paradigm describes the construc-
tion of a valve by combining cells and scaffold in vitro, followed by in vitro
maturation of the construct in a bioreactor. However, according to Rabkin and
Schoen, an alternative tissue-engineering strategy is to use scaffolds derived from nat-
ural materials that attract endogenous cells to repopulate and remodel the altered tis-
sue. For this purpose, freeze-dried porcine valves,2 decellularized porcine valves,3 or
isolated cell-free porcine small intestine submucosa (SIS)4 was used as a bioscaffold.
In a previous study, we used this concept of in vivo or endogenous cell seeding on
a cross-linked but noncytotoxic, acellular scaffold to construct a heart valve.5 We used
photo-oxidized bovine pericardium (POP) as a matrix,6 which was intraperitoneally
(IP) seeded for 3 days, to construct a valve that was subsequently implanted in the pul-
monary position. By orthotopic implantation of the valve, the heart itself functioned as
a bioreactor to induce adequate differentiation of the endogenously seeded cells. This
previous study mainly described the cellular aspects of the valves up to 1 month after
their construction. It was shown that complete recellularization was obtained and
associated with differentiation into a myofibroblast phenotype, concomitant neomatrix
deposition, and adequate reendothelialization.
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SIS 5 small intestine submucosa
In the present study, we used the same model as that in our
previous study,5 but the valves were followed up much
longer, that is, to 5 months after implantation. The analysis
focused more on functionality, durability, and biomechanical
properties than on detailed cellular characterization. Never-
theless, the evolution of recellularization and neomatrix
formation were studied during this maturation process.
Therefore, data from the previous study are partially recapit-
ulated in the actual report.
Materials and Methods
Animals
Young purebred female ‘‘Lovenaar’’ sheep (n 5 40) were selected
and allocated at random to 2 groups. Their average age was 516
6 169 days, and their average weight was 61.6 6 10.0 kg. All an-
imals were cared for by a veterinarian in accordance with the ‘‘Guide
for the Care and Use of Laboratory Animals’’ (National Institutes of
Health publication 85-23, revised 1985). The study was approved by
the Ethics Committee of the Katholieke Universiteit Leuven.
There was no early or late mortality in both groups, but animals
diagnosed with endocarditis were excluded from the study. This was
the case in 1 animal in the 5-month IP preseeded group, and the
animal was excluded from analysis.
Surgery
All sheep were premedicated with 10 to 20 mg/kg ketamine intra-
muscularly, followed by anesthetic induction with increasing con-
centrations of isoflurane in oxygen. After endotracheal intubation
and institution of mechanical ventilation, anesthesia was maintained
with isoflurane in 5 L/min O2 and 2 L/min N2O.
Group 1 sheep (n5 19) had a pericardial patch of POP (Cardio-
fix, donated by Sulzer Carbomedics, Austin, Tex) implanted in the
abdominal cavity. Three days later the sheep were again prepared
for surgery as described above. The peritoneal cavity implant was
aseptically retrieved without sacrificing the animals. The patch
was folded and sutured into a stentless valve construct5,7 and kept
in ice-cold saline until implantation in the pulmonary artery. During
the valve construction, a left thoracotomy was performed at the third
intercostal space. A cardiopulmonary bypass system was applied,
and the in vivo seeded vascular construct was implanted as an inter-
position in the pulmonary artery. The native pulmonary valve was
excised. The animals received analgesics (Dipidolor, Janssen Phar-
maceutics, Beerse, Belgium) for the first 2 days and diuretics (Lasix,
Aventis Pharma, Brussels, Belgium) when necessary. Genta-Kel
10% (Kela NV, Hoogstraten, Belgium) and Clexane (Aventis
Pharma, Brussels, Belgium) were administered intramuscularly for
7 days after the operation.396 The Journal of Thoracic and Cardiovascular Surgery c FeDuring euthanasia, the animals were first premedicated with ket-
amine, and anesthesia was induced with isoflurane in oxygen. At
this point a transthoracic echocardiography was performed (see
below). After receiving heparin, the animals were administered an
overdose of pentobarbital (Nembutal; Ovation Pharmaceuticals
Inc, Deerfield, Ill) and KCl. Subsequently the implants were re-
moved aseptically and immediately fixed in 4% paraformaldehyde.
The following experimental protocol was followed:
1) Group 1: pulmonary implants of valves not previously IP
seeded (n5 20) were explanted at 1 week (n5 6), 1 month
(n 5 6), and 5 months (n 5 8).
2) Group 2: pulmonary implants of valves previously IP seeded
(n5 19) were explanted at 1 week (n5 6), 1 month (n5 6),
and 5 months (n 5 7).
Echocardiographic Analysis
Before sacrifice or at 3 months, the animals were anesthetized and
placed on the operation table in a right lateral recumbent position
and attached to the anesthesia machine (Julian, Dra¨ger, Germany).
Sheep assigned to the 1-week and 1-month groups were assessed
before sacrifice. Overall, data were obtained at 1 week, 1 month, 3
months, and 5 months. Echocardiography was performed by an ex-
perienced echocardiographer using a Vivid Five echo system (GE
Medical Systems, Milwaukee, Wis) and a 2.5-MHz GE Ultrasound
probe (GE Medical Systems). The peak gradient was assessed with
continuous-wave Doppler, and the degree of regurgitation was
assessed with color flow Doppler echocardiography.
Biochemical and Biomechanical Valve Testing
The valves explanted at 5 months were used for the following tests:
Calcium analysis. The tissue was lyophilized, weighed, and dis-
solved in a 20% hydrochloric acid solution (10 mg dried tissue/1 mL
HCl) for 24 hours. After homogenization, samples were kept at
70C overnight. Samples were then analyzed with a Calcium-kit
(Chema Diagnostica, Monsano, Italy) and a spectrophotometer
(Multiscan EX, Thermo Electron Corp, Woburn, Mass). Calcium
levels were expressed as micrograms per milligram.
Degradation resistance. The following protease solution was
used: 96 mg of CaCl2.2H2O and 97 mg of protease (Type XIV
from Streptomyces griseus) dissolved in 180 mL of buffer consisting
of 0.01 mol/L HEPES (Gibco, Gaithersburg, Md), 0.9% (m/v) NaCl
(VWR, Heverlee, Belgium), and 0.1 mol/L glycine (Fluka, Buchs,
Switzerland). Lyophilized samples of known mass were incubated
in the protease solution for 30 hours at 37C. After removal from
the solution, samples were washed 3 times with deionized (DI) water
(5 minutes) and lyophilized. Resistance toward protease degradation
was given as the mass of remaining tissue expressed as a percentage
of the predigestion mass.
Shrinkage temperature. A tensiometer (Force transducer type
372, Hugo Sachs, Germany) was used to measure the shrinkage tem-
perature. Strips of tissue (5 mm) were sewed into rings and sub-
merged in saline solution (0.9% NaCl). The immersing solution
was gradually heated from 25C to 95C, and the temperature at
the onset of shrinkage was considered as the shrinkage temperature.
Tensile mechanical properties. Tensile tests were performed on
a custom-made uniaxial testing device comprising a 200 N load cell
(Sensy, model 2712, Jumet, Belgium). Five-millimeter wide, fullbruary 2008
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Pleaflet-length samples were clamped at an interclamp distance of 6
mm. A monotonically increasing displacement was applied at
a rate of 2 mm/min until failure occurred. E-modulus, maximal
force, and strength were calculated on the basis of force-displace-
ment curves. Samples from control and IP seeded valves were tested
immediately after sacrifice, and tests were performed at room tem-
perature in ambient air.
Sirius red for collagen organization. The following Sirius red
(SR) solution was prepared: 8 g picric acid (VWR) was dissolved
in 200 mL DI water and mixed for 30 minutes; after filtration, 0.2 g
old red (Aldrich Chemical Co, Milwaukee, Wis) was added, and
the solution was filtered a second time. After immersion in DI water
for 5 minutes, the frozen sections were submerged in the SR solution
for 90 minutes. Sections were directly placed in 0.01 N HCl and
mounted. Sections were viewed using normal and polarized light
to reveal the total collagen and organized collagen of the original
POP, respectively. Collagen content was expressed as a percentage
of total area, and organized collagen was expressed as a percentage
of total collagen.
Sirius red/Fast green for collagen content. SR/Fast green solu-
tion was prepared as described above but with the addition of 0.2 g
fast green FCF (Sigma, St Louis, Mo) before the final filtration.
After immersion in DI water for 5 minutes, 0.2 mL SR/Fast green
solution was added to the frozen sections for 30 minutes. Sections
were washed with DI water and mounted or samples were scraped
off the glass, added to 2 mL of 0.1 N NaOH in methanol for 1 min-
ute, and centrifuged. The absorbance of the supernatant was deter-
mined at 605 and 540 nm. The value corresponding to 29.1% of
the optical density at 605 nm was calculated, representing the con-
tribution of Fast green to the absorbance of SR at 540 nm. The above
value was subtracted from the absorbance at 540 nm to obtain the
corrected absorbance. Next, the absorbance at 605 nm and the cor-
rected absorbance at 540 nm were divided by their respective color
equivalences (2.08 and 38.4, respectively) to obtain the net amount
of collagen and noncollagenous protein in the section. Total protein
is the sum of both values; the amount of collagen per mg of protein
was calculated.
Assessment of residual amines. Frozen samples were lyophi-
lized, weighed, and equilibrated in 2 mL of a 4% NaHCO3 solution
for 30 minutes. After reaction with 2 mL 0.5% TNBS (Sigma) at
40C, samples were rinsed with 0.9 % NaCl solution to remove un-
reacted TNBS. After 20 hours of hydrolysis in 2 mL of 25% HCl at
100C, dilution by the addition of 8 mL of DI water, and extraction
of unreacted TNBS with 2 3 10 mL diethylether, the absorbance
values of the hydrolysates were measured at 344 nm. Residual
amines were calculated using a molar absorption coefficient of
14.600 mL/mol-1/cm-1 and expressed as micromoles of amines per
milligram of dry tissue.
Histologic Analysis and Immunohistochemistry
After overnight fixation in 4% paraformaldehyde, the samples were
incubated overnight in 20% sucrose in phosphate-buffered saline,
imbedded in Neg-50 medium (Prosan, Merelbeke, Belgium), fro-
zen, and stored at 280C. Cryosectioning was performed on a Mi-
crom HM500 OM cryostat (Prosan). The 7-mm sections were placed
on poly-L-lysine–coated slides and stored at 220C until staining.
Before immunohistochemistry was performed, the presence of cells
was verified using standard hematoxylin and eosin staining and
microscopic screening. The samples with cells present were furtherThe Journal of Thostudied with immunofluorescent staining for vimentin (clone V9,
Dako; Glostrup, Denmark), alpha smooth muscle actin (ASMA,
clone 1A4, Dako), smooth muscle heavy chain myosin (clone
SMMS-1, Dako), smoothelin (polyclonal; Santa Cruz Biotechnol-
ogy, Santa Cruz, Calif), or endothelial nitric oxide synthase (clone
3, BD Pharmingen, San Diego, Calif). DAPI, a nuclear stain, was
used for counterstaining. Microthrombi were scored on the hema-
toxylin and eosin–stained sections. The presence of elastin was
assessed on von Giessen elastica-stained sections.
The total number of cells was counted on 1 complete leaflet sec-
tion for each valve. DAPI-stained leaflets were digitally recorded,
the micrographs were assembled in a mosaic image, and the nuclei
were automatically counted using an Axioplan 2 imaging micro-
scope and Axiovision 4.2 software package (Zeiss, Zaventem, Bel-
gium). The same setup was used to perform morphometry and image
analysis. For cell phenotyping, except for endothelial nitric oxide
synthase, a total of 500 cells were assessed for each leaflet, and
the results were expressed as a percentage. To avoid bias, several
pictures for each leaflet were taken, quartered, and counted accord-
ing to a randomization list.
Statistical Analysis
Generally, we used nonparametric statistics because of the limited
number of observations in each group. Continuous data from the dif-
ferent groups were first compared with a Kruskal–Wallis test. If the
obtained P value was less than .05, appropriate comparisons be-
tween the groups were performed by means of a Wilcoxon Mann–
Whitney test. The echocardiographic data obtained at different
time points were analyzed with a linear regression model. All of
these tests were performed with the Statistical Package for the Social
Sciences 14.0 for Windows (SPSS Inc, Chicago, Ill).
The score for calcification data was analyzed with a chi-square
test. Because the regurgitation and microthrombus data were ob-
tained at different time points, they were analyzed with stratified
23 2 tables and the Mantel–Haenszel inference statistic test. These
analyses were performed with StatXact 4.0.1 software (Cytel Inc,
Cambridge, Mass).
Results
Hemodynamic Performance
Figure 1 summarizes the hemodynamic data obtained from
transthoracic echocardiography. As shown in the upper
panel, the pressure gradient across the valve decreased pro-
gressively with time in both groups (P5 .008) but was higher
in the IP seeded valves at all time points (P 5 .040). These
valves had also an increasing incidence of regurgitation
with time (P 5 .018). The degree of regurgitation, however,
remained mild (ie, not .2/4).
Macroscopic and Microscopic Valve Properties
Macroscopic appearance. The IP valves were markedly
remodeled, and the leaflets had a nest-like appearance similar
to native valves, with the formation of pronounced commis-
sures. The leaflets of the non-preseeded valves had a more
abundant, billowing appearance (Figure 2).racic and Cardiovascular Surgery c Volume 135, Number 2 397
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a preserved length and a small increase in thickness (Figure 3,
A and B). Conversely, the IP seeded valves showed a gradual
decrease in length, resulting in double the thickness of the
non-preseeded valves through 5 months in the pulmonary po-
sition (P5 .021). A concomitant shortening of the IP valves
was also observed resulting in a 17% (P 5 .004) and 32%
(P 5 .029) decrease in leaflet length at 1 and 5 months,
respectively. The amount of newly deposited material was
also measured in the sections and is represented as the
Figure 1. Hemodynamic assessment by transthoracic echocardi-
ography. A, Peak pressure gradients across the pulmonary valve
at 1 week, 1 month, 3 months, and 5 months after valve replace-
ment. Linear regression: peak gradient (P 5 .040) and time (P 5
.008) were shown to be significant factors. Mean and standard de-
viation (dots and bars). B, Incidence of pulmonary valve regurgita-
tion (score<1ˇ/4 ) at 1 week, 1 month, 3 months, and 5 months after
valve replacement. Common odds ratio estimate: 11.27 (1.51; 84.22);
homogeneity P5 .220; odds ratio5 test; P5 .018 (Mantel–Haens-
zel inference). IP, Intraperitoneal.398 The Journal of Thoracic and Cardiovascular Surgery c Febpercentage of the leaflet covered with new material
(Kruskal–Wallis: P , .001) and the surface of new material
(Kruskal–Wallis; P5 .002). In controls, leaflet coverage was
28.9% 6 29.8% and 11.7% 6 8.3% at 1 week and 1 month,
respectively, and increased significantly to 62.6% 6 30.0%
at 5 months (P 5 .001 vs 1 month). The leaflet coverage of
the IP valves, 90.0% 6 16.8%, 65.7% 6 28.8%, and
89.8% 6 26.5% at 1 week, 1 month and 5 months, respec-
tively, did not differ significantly over time. However, it
was significantly higher than that of the controls at each time
point assessed (P 5 .004, P 5 .002, and P 5 .009, respec-
tively). The tissue overgrowth data largely coincide with the
previous data. The controls had a limited amount of new
material, 3.57 6 4.92 mm2, 1.17 6 0.80 mm2, and 1.74 6
1.39 mm2 at 1 week, 1 month, and 5 months, respectively.
These values showed no significant difference. With excep-
tion of the 8.746 5.30 mm2 observed at 1 week, the 9.466
5.47 mm2 (P5 .009) and 7.626 4.03 mm2 (P5 .001) of new
material in IP valves at 1 month and 5 months, respectively,
were significantly higher than their time-related controls.
Where present, the deposited new material stained positive
for elastin in both groups, as did the native pulmonary valves
(Figure 4, A–C).
Next, we studied the original matrix by assessing the
amount and organization of the collagen by means of SR-
stained sections (Figure 5, Polarized Sirius Red). The scaf-
fold’s collagen density (Figure 3, C) remained stable in
both groups at all time periods. However, although a sig-
nificant yet small increase in the amount of organized
collagen (Figure 3, D) in the control was noted at 1 week
Figure 2. Macroscopic appearance of the valve explanted at
5 months. A, IP preseeded valve. Note the nest-like appearance
of the leaflet. B, control (nonpreseeded valve). The leaflets are
abundant and billowing. IP, Intraperitoneal.ruary 2008
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P(P5 .041), a marked decrease in organization was observed
in both the control and IP valves (P5 .001 and .001, respec-
tively).
A limited presence of microthrombi could be observed in
both groups at all time points, but the prevalence did not
show a significant difference between the groups (Mantel–
Haenszel inference: P 5 .650). The controls had 2/6, 1/6,
and 3/8, and IP valves had 3/6, 2/6, and 2/7 microthrombi-
positive valves at 1 week, 1 month, and 5 months, respec-
tively.
Recellularization
We found that the number of cells in the IP valve sections sig-
nificantly exceeded that of the controls 4- to 5-fold at all time
points (P, .050) (Figures 3, E, and 5, Nuclei). However, we
also measured the cells in sections of native pulmonary
valves (7482 6 1168 cells/section) and plotted them in the
same graph, thus showing that controls and IP valves were
under- and overcellularized, respectively. Next we studied
the presence of 4 markers: vimentin, ASMA, SMMS-1,
and smoothelin, expressed by (myo)fibroblasts and smooth
muscle cells (Table 1).
The fraction of cells that were positive for vimentin (a
mesenchymal marker) and ASMA (a marker of myofibro-
blasts and smooth muscle cells) was equal in both the control
and IP valves. For ASMA, the fractions of both groups signif-
icantly exceeded the proportion of these cells found in native
pulmonary valves (P , .001 and 5 .001, respectively). On
the other hand, the fraction of smooth muscle cells, as as-
sessed by SMMS-1 and smoothelin, was limited in control
and IP valves only. All valves demonstrated re-endotheliali-
zation as shown by immunofluorescent staining for endothe-
lial nitric oxide synthase (Figure 4, D–F).
Valve Characteristics at 5 Months of Implantation
All the results of this section are summarized in Table 2. Cal-
cification scores of electron-dense regions (Faxitron, Wheel-
ing, Ill) showed that these were present in comparable
proportions in both the control and IP valves. This finding
was confirmed by absolute quantification of the calcium con-
tent. The values did not exceed those found in unimplanted
matrix or the native pulmonary valve.
Protease degradation, a measure of the prosthesis’ resis-
tance to degradation, showed that the control and IP valves
had a similar resistance as the unimplanted matrix. However,
the native valves showed a significantly lower degradation
resistance compared with the original matrix (P, .001), con-
trol (P 5 .011), and IP (P 5 .002) valves. Collagen content
was comparable among the original matrix, control, and IP
valves. The free amines used to assess cross-linking effi-
ciency showed low levels in unimplanted POP and equally
increased levels in both control (P 5 .001) and IP valves
(P 5 .001). However, they never attained the high level ofThe Journal of Thofree amines found in unfixed native pulmonary valves (P 5
.016 and .002, respectively).
The shrinkage temperature of the control (P , .001) and
IP valves (P , .001) was significantly lower compared
with that of the matrix material. The shrinkage temperature
of native valves was significantly higher than that of the con-
trol valves (P, .001), the IP valves (P, .001), and even the
POP (P , .001). Mechanical tests showed a significant de-
crease in stiffness (E-modulus) in both control (P 5 .013)
and IP valves (P, .001) compared with POP. The IP valves
had a significantly lowered E-modulus compared with con-
trols (P 5 .008). Control valves had a significantly higher
E-modulus than native valves (P5 .008), whereas IP valves
were comparable to native valves. Because the E-modulus is
calculated from the stress–strain curves combined with the
sample’s cross-section, one might argue that we do not
have a homogeneous material and should therefore take
into account only the original matrix. However, recalculating
the E-modulus in this way (5.306 2.69 MPa) did not change
the findings. The maximal force attained before rupture
(Fmax) showed a comparable yet significant decrease in
Fmax of both control (P 5 .004) and IP valves (P 5 .008)
compared with POP. However, they were both significantly
higher than the Fmax from native valves (P 5 .001 and
.002, respectively). Strength showed significant decreases
in control (P 5 .001) and IP (P , .001) valves compared
with POP. Although no significant difference between both
valve groups was detected, control (P 5 .043) valves still
had a significantly higher strength than the native valves,
whereas IP valves were comparable to native valves. Here
again, taking into account the original POP cross-section,
the strength of the IP valves increased to 3.52 6 0.93 MPa,
which became significantly higher than the values of the
native valves (P 5 .004).
Discussion
In the past, scaffolds derived from natural materials that at-
tract endogenous cells, such as freeze-dried porcine valves,2
decellularized porcine valves,3 or isolated cell-free porcine
SIS,4 were used in tissue engineering of heart valves. With
respect to the freeze-dried porcine valves, the matrix proper-
ties were altered. Perforations allowing fibroblast infiltration
and gentle abrasion of the surface to enhance endothelial cell
adhesion showed positive results,2 but further in vivo evalu-
ation is certainly necessary. Their protocol also killed the
original porcine cells by a freeze-drying process, and within
the 10-day culturing period the cell remnants disintegrated.2
Here again, in vivo studies are imperative because similar
prostheses have shown detrimental inflammatory complica-
tions on implantation in patients.8 The groups of Elkins and
colleagues3 and Matheny and colleagues4 assessed recellula-
rization of decellularized porcine valves and cell-free porcine
SIS in the pulmonary position in sheep and swine, respec-
tively. In both cases, the grafts became recellularized withracic and Cardiovascular Surgery c Volume 135, Number 2 399
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De Visscher et al Cardiopulmonary Support and PhysiologyFigure 4. Representative images of Von
Giessen stained (A–C) and endothelial
nitric oxide synthase immunofluores-
cent (D–F) sections. The elastic fibers
(A–C), present in all deposited material
and the native valve, are visible as
black stained fibers and examples are
marked with arrows. The green fluores-
cence (D–F) represents the endothelial
nitric oxide synthase positive cells,
and the nuclei are counterstained with
DAPI (blue dots). IP, Intraperitoneal;
eNOS, endothelial nitric oxide syn-
thase.SPlargely the same cell populations. However, 1 major differ-
ence was that SIS, which was assessed after a shorter time
in the pulmonary position, was resorbed and replaced by
new matrix material.4 Also, handmade valves similar to the
one used here made from SIS have been implanted in the pul-
monary position in sheep.9 These valves showed immediate
function, but only limited follow-up and functional analysis
were performed.
The concept of IP seeding originates from a first attempt to
grow an artificial artery graft out of granulation tissue, known
as the ‘‘Sparks mandril’’ prosthesis.10 More recently, Camp-
bell and coworkers11 showed the construction of a functionalThe Journal of Thovascular graft generated from an IP deposited capsule around
an implanted silastic tube. This tube (or foreign body) was
left in the peritoneal cavity for several weeks until a complete
encapsulation was obtained. After removal of the tube, they
everted the capsule to internalize the exterior mesothelial
layer and implanted the grafts in the abdominal aorta of
both rats and rabbits. In this approach, the seeding is done
by the graft recipient itself. The difference between our
approach and that of Campbell and coworkers11 is that we
did not leave the scaffold in the peritoneal cavity for the
whole maturation process of encapsulation. We used only
the initial IP ‘‘seeding phase,’’ that is, at 3 days IPCFigure 3. Data are represented as box plots with the horizontal marker and box representing the median and inter-
quartile range and the whiskers showing the distance from the end of the box to the largest and smallest observed
values less than 1.5 box lengths from either end of the box. *Significant difference from the IP valves at the same
time point. #Significant difference from the 1-week group within the same seeding group. ySignificant difference
from the 1-month group within the same seeding group. The reported P values are obtained from the Kruskal–Wallis
test for multiple unpaired samples. A, Leaflet length measured on hematoxylin and eosin–stained cross-sections.
The designed preimplant leaflet length (dashed line). B, Leaflet thickness measured on hematoxylin and eosin–
stained cross-sections. Thickness of unimplanted POP (line) and 95% CI (gray area). C, Collagen density of the
POP in the valves assessed by picrosirius red staining. Collagen density of unimplanted POP (line) and 95% CI
(gray area). D, Organized collagen of the POP in the valves assessed by picrosirius red staining. The organized
collagen of unimplanted POP (line) and the 95% CI (gray area). E, Total cell count (left axis) of the valve leaflet
and comparison with a native pulmonary heart valve (right axis). Total cell count of a native sheep pulmonary valve
leaflet (line) and 95% CI (gray area). IP, Intraperitoneal.racic and Cardiovascular Surgery c Volume 135, Number 2 401
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cells.5,12 After 3 days we removed the scaffold from the peri-
toneal cavity and sutured it into a valve construct that was
implanted in the pulmonary position for up to 5 months.
In our actual study, all valves remained functional for at
least 5 months. However, the valves that were IP preseeded
had a consistently higher peak gradient and an increased ten-
dency for regurgitation. The likely reason for both these fea-
tures was the excess cellularization after IP preseeding
compared with controls, which was observed immediately
after implantation. Both groups also showed bidirectional
variation in recellularization (data not shown). In addition
Figure 5. Representative images of nuclei density and picrosirius
red stained sections of control and IP valves. The nuclei density
maps were obtained by determining the X and Y coordinates of
each individual nucleus on DAPI-stained sections and calculating
a density map with the TOPCAT online software package (Mark
Taylor, http://www.starlink.ac.uk/topcat/). The picrosirius red
stained sections show the red stained collagen; in organized col-
lagen bundles photographed with polarized light, the collagen is
shown in blue pseudo-color. IP, intraperitoneal.402 The Journal of Thoracic and Cardiovascular Surgery c Febto recellularization, we also found a significant amount of
new matrix material deposited on the photo-oxidized scaffold
of IP valves. This new material approximately doubled the
leaflet cross-sectional surface and therefore inherently its
mass. This increased resistance explains the observed higher
peak gradients. The increase in new material could not be
attributed to thrombosis because both groups were minimally
thrombogenic. The gradual decrease of peak gradients over
time is expected in stentless valves.13 With respect to the in-
creased regurgitation, we observed extensive shortening of
the leaflets in the IP valves, resulting in inadequate coapta-
tion. The reason behind the shrinkage became apparent
when the sections were stained for the presence of myofibro-
blasts and smooth muscle cells. These cells with contractile
properties normally represent only a minority of cells in a na-
tive leaflet, and almost all other cells are fibroblasts. In native
pulmonary valves, only 2% to 5% of these cells are myofibro-
blasts and almost none are smooth muscle cells,14 although
increased amounts of these cells have been observed in path-
ologic conditions15,16 and in vitro cultured interstitial valve
cells.17,18 In our valve constructs, be it preseeded or sponta-
neously recellularized, an excess of cells stained for ASMA.
In the preseeded valves, we found the same for smoothelin.
Although both valve constructs, controls and preseeded,
had a significantly increased proportion of ASMA or smooth-
elin-positive cells, leaflet shortening was only observed in
preseeded valves. This can be explained by the difference
in degree of recellularization. In the valves left to recellular-
ize spontaneously, significantly less cells, leaflet coverage,
and new matrix deposition were found. Conversely, pre-
seeded valves were excessively recellularized, resulting in
a severe overshoot of the absolute number of cells with con-
tractile properties. Although this may explain the 15% to
20% shortening of the leaflets of the preseeded valve con-
struct, inducing malcoaptation, the leaflets still moved freely
and functioned well. Obviously this process of recellulariza-
tion is completely different from the process of excessive
pannus overgrowth, as can be seen in some glutaraldehyde-
fixed bioprostheses, called ‘‘open regurgitation.’’ This is
found in pediatric patients and is a result of exaggerated pan-
nus formation overgrowing the leaflets and adhering them to
the wall.19 It should also be considered that the valves were
constructed with almost no coaptation area, and thereforeTABLE 1. Immunofluorescent staining
Control valves IP valves Native valves P value
Vimentin (%) 46.9 6 14.9 38.5 6 16.9 ND .336
ASMA (%) 39.0 6 16.2* 30.5 6 19.5* 1.4 6 0.9 .001
SMMS-1 0.00 6 0.00 0.00 6 0.00 0.00 6 0.00 1.000
Smoothelin 1.42 6 1.53* 3.62 6 2.43* 0.00 6 0.00 .005
IP, Intraperitoneal; ASMA, alpha smooth muscle actin; ND, not determined. Data are presented as mean6 standard deviation. *Significant differences from
native valve.ruary 2008
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POP Control valves IP valves Native valves P value
I. Calcification
X-ray score ND 5/8 2/7 ND .183 (c2)
Ca content (mg/mg) 0.62 6 1.10 3.37 6 2.75 3.03 6 3.70 3.86 6 5.00 .085 (KW)
II. Biochemical properties
Protease degradation (%) 65.2 6 2.9* 58.5 6 6.8* 63.1 6 5.0* 40.8 6 14.7 ,.001 (KW)
Collagen content (mg/mg) 51.1 6 17.7 40.5 6 19.6 38.3 6 19.2 ND .221 (KW)
Free amines (mmol/mg) 20.9 6 1.4* 90.9 6 34.3*y 76.8 6 13.4*y 200.0 6 132.5y ,.001 (KW)
III. Biophysical properties
Shrinkage temperature (C) 59.4 6 0.7* 56.1 6 0.9*y 56.1 6 1.2*y 63.3 6 0.8y ,.001 (KW)
E (MPa) 19.43 6 6.18* 11.56 6 6.98*y 3.67 6 2.33yz 3.37 6 1.91y ,.001 (KW)
F max (N) 25.8 6 9.1* 15.4 6 6.6*y 14.6 6 6.0*y 2.4 6 1.0y ,.001 (KW)
Strength (MPa) 8.28 6 2.60* 4.08 6 2.10*y 2.33 6 1.07y 1.56 6 0.65y ,.001 (KW)
POP, Photo-oxidized bovine pericardium; IP, intraperitoneal; ND, not determined. Data are presented as mean 6 standard deviation. *Significant difference
from native valve. ySignificant difference from unimplanted matrix material (Cardiofix, donated by Sulzer Carbomedics, Austin, Tex). zSignificant difference
from spontaneous seeded valve. For the tensile strength–related variable, the correction was made with the original matrix only.CS
Pthe slightest shrinkage of the leaflets will induce malcoapta-
tion. Another crucial cell type in a normal native valve is the
endothelial cell. As shown previously, IP seeding leads to re-
endothelialization, most probably by attraction of endothelial
progenitors from the circulation.5 At 5 months this observa-
tion was confirmed, as was endothelialization of the pannus
growing on the control valves.
Calcification, a major problem with commercially avail-
able valves,20,21 is determined by several factors, as previ-
ously reported;22 this includes the material used to make
the valve prosthesis. The fact that photo-oxidized pericar-
dium is resilient to calcification23,24 was confirmed, and no
difference in calcification among the unimplanted matrix,
spontaneously seeded, and IP valves was observed. Further-
more, the IP valves had a calcium content comparable to that
of native sheep pulmonary valves.
In heart valve tissue engineering, a slowly degradable
scaffold is preferred because the construct must withstand
the stress implied by the circulation immediately after im-
plantation and in the initial phase of recellularization. The
photo-oxidized scaffold slowly degrades, as shown by the
severe decrease in collagen organization of the matrix at 5
months. However, the collagen concentration and density
remain unaltered. This clearly shows that when new matrix
is deposited, it contains comparable amounts of collagen as
the matrix. The photo-oxidized pericardium is more prone
to slow degradation than glutaraldehyde-fixed pericardium.
This is shown by resistance to degradation, which is lower
for photo-oxidized than for glutaraldehyde-fixed pericardium
(data not shown). This degradation occurs in the controls and
the preseeded valves, and clearly affects the biophysical
properties of the valves. As discussed above, changes in
shrinkage temperature were observed, but more pertinent de-
creases in stiffness, maximal force, and strength were found.
The decrease in maximal force was equal in both spontaneousThe Journal of Thorand IP valves. Although only significant in the stiffness, both
stiffness (E-modulus) and strength were decreased even fur-
ther in IP preseeded valves. Because the IP valves had a larger
cross-section because of the new material, we also adjusted
the calculation by only taking into account the thickness of
the original matrix. This resulted in increases in the obtained
E-modulus and strength values, but even then the stiffness of
the IP valves remained significantly lower than that of con-
trols. Nevertheless, the biophysical properties of the valve
constructs were still superior to those of the native pulmonary
valves at 5 months after implantation. Two additional vari-
ables, the shrinkage temperature and amount of free amines,
could contribute to evidence of degradation, but this could
also be contributed to the deposition of new extracellular ma-
trix material. Shrinkage temperature, a hallmark for cross-
linking, showed a small but significant decrease after implan-
tation with or without preseeding. Whether this decrease is
attributed to degradation or a lower shrinkage temperature of
a possibly less structured new matrix could not be accurately
measured by our techniques. However, a biphasic shrinkage
profile, measurable in composite materials or genipin-fixed
pericardium subcutaneously implanted in rats,25 could not
be observed. The large increase in free amines observed in
controls and IP seeded valves can similarly be attributed to
degradation and the deposition of new material containing
increased amounts of free amines.
A limitation of the technology used to determine these
biophysical properties is that we did not account for the
anisotropy. This was impossible because we did not have
enough material to perform additional tensile tests in the
transverse direction. However, none of the obtained measure-
ments were below that of a native pulmonary valve assessed
in the same direction. In this respect it would also have been
interesting to obtain the mechanical properties of the new
matrix deposited by the cells.acic and Cardiovascular Surgery c Volume 135, Number 2 403
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CSPConclusions
Our findings confirm that IP seeding leads to recellularization
of heart valve constructs. However, the recellularization was
excessive, and the increased amount of cells with contractile
properties resulted in shortening of the leaflet and mild, yet
progressive, regurgitation of these valves. From these exper-
iments it became obvious that the problem with this seeding
protocol is not the excessive recellularization, although it
influenced the pressure gradients across the valve, but the in-
creased amount of cells with contractile properties. At pres-
ent it is not clear whether the retraction of the leaflets is
ongoing. Theoretically, modified valve design with more re-
dundancy of the leaflets could improve coaptation after valve
maturation. However, we think that the search for an adapted
seeding protocol optimizing valve cell type distribution is
mandatory.
The authors thank laboratory assistants Ruth Plusquin, Veerle
Leunens, Monique Vercalsteren, and Kristof Reyniers.
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